UBS Group’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-201,655
| Closed | -$74K | – | 10448 |
|
|
2025
Q2 | $74K | Buy |
201,655
+85,207
| +73% | +$28.4K | ﹤0.01% | 7470 |
|
|
2025
Q1 | $30.2K | Buy |
116,448
+27,818
| +31% | +$15.9K | ﹤0.01% | 7940 |
|
|
2024
Q4 | $49.9K | Buy |
88,630
+46,040
| +108% | +$27.2K | ﹤0.01% | 7294 |
|
|
2024
Q3 | $25.6K | Buy |
42,590
+26,761
| +169% | +$39.7K | ﹤0.01% | 7225 |
|
|
2024
Q2 | $42.7K | Sell |
15,829
-106,736
| -87% | -$402K | ﹤0.01% | 6822 |
|
|
2024
Q1 | $629K | Sell |
122,565
-5,900
| -5% | -$19.1K | ﹤0.01% | 5012 |
|
|
2023
Q4 | $69K | Buy |
128,465
+3,904
| +3% | +$2.07K | ﹤0.01% | 6376 |
|
|
2023
Q3 | $82.6K | Buy |
124,561
+108,483
| +675% | +$110K | ﹤0.01% | 5959 |
|
|
2023
Q2 | $24.4K | Buy |
16,078
+15,978
| +15,978% | +$42.1K | ﹤0.01% | 6791 |
|
|
2023
Q1 | $190 | Sell |
100
-1,682
| -94% | -$2.17K | ﹤0.01% | 9146 |
|
|
2022
Q4 | $1.69K | Buy |
+1,782
| New | +$1.81K | ﹤0.01% | 9811 |
|
|
2022
Q1 | – | Sell |
-2,420
| Closed | -$15K | – | 10405 |
|
|
2021
Q4 | $15K | Buy |
+2,420
| New | +$16.7K | ﹤0.01% | 8243 |
|
|
2021
Q3 | – | Sell |
-1,045
| Closed | -$14K | – | 9670 |
|
|
2021
Q2 | $14K | Buy |
+1,045
| New | +$12.9K | ﹤0.01% | 7701 |
|
